total | level-I-hospitals | level-II/III-hospitals | p-value of levels | ||||||
---|---|---|---|---|---|---|---|---|---|
n = 7881 | n = 927 | n = 6954 | |||||||
age | <.0001 | ||||||||
years | mean (SD) | 74.6 | (12.8) | 76.42 | (12.2) | 74.36 | (12.9) | ||
sex | 0.0029 | ||||||||
male | n(%) | 4070 | (51.6) | 436 | (47.0) | 3634 | (52.3) | ||
female | n(%) | 3811 | (48.4) | 491 | (53.0) | 3320 | (47.7) | ||
diagnosis | <.0001 | ||||||||
transient ischaemic attack | TIA | n(%) | 1938 | (24.6) | 334 | (36.0) | 1604 | (23.1) | |
ischaemic stroke | IS | n(%) | 5409 | (68.6) | 527 | (56.9) | 4882 | (70.2) | |
haemorrhagic stroke | HS | n(%) | 504 | (6.4) | 44 | (4.8) | 460 | (6.6) | |
undefined stroke | US | n(%) | 30 | (0.4) | 22 | (2.4) | 8 | (0.1) | |
treatment | |||||||||
#lyse iv | n(%) | 1113 | (20.6) | 50 | (9.5) | 1063 | (21.8) | <.0001 | |
#lyse ia | n(%) | 68 | (1.3) | 1 | (0.2) | 67 | (1.4) | 0.0206 | |
#thrombectomy | n(%) | 226 | (4.2) | 2 | (0.4) | 224 | (4.6) | <.0001 | |
ventilation | n(%) | 378 | (4.8) | 25 | (2.7) | 353 | (5.1) | 0.0014 | |
diagnostics | |||||||||
dysphagia screening | n(%) | 6895 | (87.5) | 396 | (42.7) | 6499 | (93.5) | <.0001 | |
long-term ECG | n(%) | 7206 | (91.4) | 844 | (91.1) | 6362 | (91.5) | 0.6134 | |
extracranial | n(%) | 7457 | (94.6) | 780 | (84.1) | 6677 | (96.0) | <.0001 | |
< 48 h | n(%) | 7003 | (88.9) | 583 | (62.9) | 6420 | (92.3) | ||
> = 48 h | n(%) | 454 | (5.8) | 197 | (21.3) | 257 | (3.7) | ||
intracranial | n(%) | 7223 | (91.7) | 571 | (61.6) | 6652 | (95.7) | <.0001 | |
< 48 h | n(%) | 6939 | (88.1) | 548 | (59.1) | 6391 | (91.9) | ||
> = 48 h | n(%) | 284 | (3.6) | 23 | (2.5) | 261 | (3.8) | ||
NIHSS – at admission | 0.0290 | ||||||||
median (IQR) | 3 | (1–7) | 3 | (1–6) | 3 | (1–7) | |||
0 | n(%) | 1343 | (17.1) | 168 | (18.1) | 1175 | (16.9) | ||
1–4 | n(%) | 3643 | (46.2) | 406 | (43.8) | 3237 | (46.6) | ||
5–15 | n(%) | 2227 | (28.3) | 289 | (31.2) | 1938 | (27.89) | ||
16–20 | n(%) | 371 | (4.7) | 29 | (3.1) | 342 | (4.9) | ||
21–42 | n(%) | 294 | (3.7) | 35 | (3.8) | 259 | (3.7) | ||
mRS – at admission | |||||||||
median (IQR) | 3 | (1–4) | 3 | (1–4) | 3 | (1–4) | |||
0–1 | n(%) | 2191 | (27.8) | 267 | (28.8) | 1924 | (27.7) | 0.4751 | |
2–6 | n(%) | 5686 | (72.2) | 660 | (71.2) | 5026 | (72.3) | ||
0–2 | n(%) | 3809 | (48.4) | 454 | (49.0) | 3355 | (48.3) | 0.6880 | |
3–6 | n(%) | 4068 | (51.6) | 473 | (51.0) | 3595 | (51.7) | ||
mRS – at discharge | |||||||||
median (IQR) | 2 | (0–3) | 2 | (0–3) | 2 | (0–3) | |||
0–1 | n(%) | 3616 | (45.9) | 453 | (48.9) | 3163 | (45.5) | 0.0550 | |
2–6 | n(%) | 4259 | (54.0) | 474 | (51.1) | 3785 | (54.5) | ||
0–2 | n(%) | 5170 | (65.7) | 670 | (72.3) | 4500 | (64.8) | <.0001 | |
3–6 | n(%) | 2705 | (34.4) | 257 | (27.7) | 2448 | (35.2) | ||
Barthel Index – at admission | 0.0003 | ||||||||
mean (SD) | 62.50 | (35.1) | 60.81 | (34.3) | 62.72 | (35.2) | |||
median (IQR) | 75.00 | (37.5–100) | 52.50 | (37.5–100) | 75.00 | (37.5–100) | |||
Barthel Index – at discharge | <.0001 | ||||||||
mean (SD) | 73.28 | (32.7) | 75.07 | (29.8) | 73.05 | (33.1) | |||
median (IQR) | 87.50 | (50.5–100) | 87.50 | (62.5–100) | 87.50 | (50–100) | |||
Comorbidities | |||||||||
diabetes | n(%) | 2038 | (25.9) | 255 | (27.5) | 1783 | (25.6) | 0.2243 | |
hyper tonus | n(%) | 6798 | (86.3) | 805 | (86.8) | 5993 | (86.2) | 0.5983 | |
atrial fibrillation | n(%) | 2301 | (29.2) | 263 | (28.4) | 2038 | (29.3) | 0.8371 | |
previous stroke | n(%) | 2269 | (28.8) | 238 | (25.7) | 2031 | (29.2) | 0.0253 | |
onset-to-door-time | <.0001 | ||||||||
< =1 h | n(%) | 892 | (11.3) | 63 | (6.8) | 829 | (11.9) | ||
1-2 h | n(%) | 1436 | (18.2) | 144 | (15.5) | 1292 | (18.6) | ||
2-3 h | n(%) | 780 | (9.9) | 94 | (10.1) | 686 | (9.9) | ||
3-3.5 h | n(%) | 257 | (3.3) | 48 | (5.2) | 209 | (3.0) | ||
3.5-4 h | n(%) | 238 | (3.0) | 34 | (3.7) | 204 | (2.9) | ||
4-6 h | n(%) | 562 | (7.1) | 77 | (8.3) | 485 | (7.0) | ||
6-24 h | n(%) | 1383 | (17.6) | 189 | (20.4) | 1194 | (17.2) | ||
24-48 h | n(%) | 564 | (7.12) | 85 | (9.2) | 479 | (6.9) | ||
> 48 h | n(%) | 812 | (10.3) | 58 | (6.3) | 754 | (10.9) | ||
unknown | n(%) | 953 | (12.1) | 135 | (14.6) | 818 | (11.8) | ||
#door-to-needle-time | <.0001 | ||||||||
< =30 min | n(%) | 619 | (11.5) | 4 | (0.8) | 615 | (12.6) | ||
30-60 min | n(%) | 409 | (7.6) | 29 | (5.5) | 380 | (7.8) | ||
> 60 min | n(%) | 147 | (2.7) | 17 | (3.2) | 130 | (2.7) | ||
no lysis applied | n(%) | 4232 | (78.3) | 477 | (90.5) | 3755 | (77.0) | ||
length of stay | 0.1129 | ||||||||
days | mean (SD) | 8.5 | (6.3) | 8.8 | (6.4) | 8.4 | (6.3) | ||
secondary prevention | |||||||||
anticoagulation | n(%) | 1999 | (25.4) | 244 | (26.3) | 1755 | (25.2) | 0.4836 | |
VitKAnt | n(%) | 923 | (11.7) | 130 | (14.0) | 793 | (11.4) | ||
NOAK | n(%) | 1076 | (13.7) | 114 | (12.3) | 962 | (13.8) | ||
statins | n(%) | 5827 | (73.9) | 763 | (82.3) | 5064 | (72.8) | <.0001 | |
IPA within 48 h | n(%) | 6053 | (76.8) | 770 | (83.1) | 5283 | (76.0) | <.0001 | |
IPA at discharge | n(%) | 5534 | (70.2) | 673 | (72.6) | 4861 | (69.9) | 0.0281 | |
in-hospital mortality | 0.4158 | ||||||||
n(%) | 423 | (5.4) | 55 | (5.9) | 568 | (5.3) | |||
reason of discharge | <.0001 | ||||||||
end of treatment as scheduled | n(%) | 4938 | (62.9) | 729 | (78.6) | 4209 | (60.6) | ||
end of treatment due to other reason | n(%) | 123 | (1.6) | 14 | (1.5) | 109 | (1.6) | ||
transfer to other hospital | n(%) | 477 | (6.1) | 46 | (5.0) | 431 | (6.2) | ||
transfer to acute rehabilitation | n(%) | 1358 | (17.2) | 68 | (7.3) | 1290 | (18.6) | ||
transfer to skilled nursing facility | n(%) | 455 | (5.8) | 13 | (1.4) | 442 | (6.4) | ||
transfer to other department | n(%) | 107 | (1.4) | 2 | (0.2) | 105 | (1.5) | ||
death | n(%) | 420 | (5.3) | 55 | (5.9) | 365 | (5.3) |